Dipak K. Dey
University of Connecticut
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Dipak K. Dey.
Molecular Ecology | 2002
Kent E. Holsinger; Paul O. Lewis; Dipak K. Dey
Molecular markers derived from polymerase chain reaction (PCR) amplification of genomic DNA are an important part of the toolkit of evolutionary geneticists. Random amplified polymorphic DNA markers (RAPDs), amplified fragment length polymorphisms (AFLPs) and intersimple sequence repeat (ISSR) polymorphisms allow analysis of species for which previous DNA sequence information is lacking, but dominance makes it impossible to apply standard techniques to calculate F‐statistics. We describe a Bayesian method that allows direct estimates of FST from dominant markers. In contrast to existing alternatives, we do not assume previous knowledge of the degree of within‐population inbreeding. In particular, we do not assume that genotypes within populations are in Hardy–Weinberg proportions. Our estimate of FST incorporates uncertainty about the magnitude of within‐population inbreeding. Simulations show that samples from even a relatively small number of loci and populations produce reliable estimates of FST. Moreover, some information about the degree of within‐population inbreeding (FIS) is available from data sets with a large number of loci and populations. We illustrate the method with a reanalysis of RAPD data from 14 populations of a North American orchid, Platanthera leucophaea.
Canadian Journal of Statistics-revue Canadienne De Statistique | 2003
Sujit K. Sahu; Dipak K. Dey; Márcia D. Branco
The authors develop a new class of distributions by introducing skewness in multivariate ellip- tically symmetric distributions. The class, which is obtained by using transformation and conditioning, contains many standard families including the multivariate skew-normal and distributions. The authors obtain analytical forms of the densities and study distributional properties. They give practical applica- tions in Bayesian regression models and results on the existence of the posterior distributions and moments under improper priors for the regression coefficients. They illustrate their methods using practical examples.
Test | 2002
Barry C. Arnold; Robert J. Beaver; Adelchi Azzalini; N. Balakrishnan; A. Bhaumik; Dipak K. Dey; Carles M. Cuadras; José María Sarabia
The univariate skew-normal distribution was introduced by Azzalini in 1985 as a natural extension of the classical normal density to accommodate asymmetry. He extensively studied the properties of this distribution and in conjunction with coauthors, extended this class to include the multivariate analog of the skew-normal. Arnold et al. (1993) introduced a more general skew-normal distribution as the marginal distribution of a truncated bivariate normal distribution in whichX was retained only ifY satisfied certain constraints. Using this approach more general univariate and multivariate skewed distributions have been developed. A survey of such models is provided together with discussion of related inference questions.
Journal of the American Statistical Association | 1997
Debajyoti Sinha; Dipak K. Dey
Abstract This review article investigates the potential of Bayes methods for the analysis of survival data using semiparametric models based on either the hazard or the intensity function. The nonparametric part of every model is assumed to be a realization of a stochastic process. The parametric part, which may include a regression parameter or a parameter quantifying the heterogeneity of a population, is assumed to have a prior distribution with possibly unknown hyperparameters. Careful applications of some recently popular computational tools, including sampling-based algorithms, are used to find posterior estimates of several quantities of interest even when dealing with complex models and unusual data structures. The methodologies developed herein are motivated and aimed at analyzing some common types of survival data from different medical studies; here we focus on univariate survival data in the presence of fixed and time-dependent covariates, multiple event-time data for repeated nonfatal events, ...
Archive | 2000
Dipak K. Dey; Sujit K. Ghosh; Bani K. Mallick
Part 1 Extending the GLMs. Part 2 Categorical and longitudinal data. Part 3 Semiparametric approaches. Part 4 Model diagnositics and value selection in GLMs. Part 5 Challenging problems in GLMs.
Diabetes, Obesity and Metabolism | 2004
Harry G. Preuss; Debasis Bagchi; Manashi Bagchi; C. V. S. Rao; Dipak K. Dey; S. Satyanarayana
Aim: The efficacy of optimal doses of highly bioavailable (–)‐hydroxycitric acid (HCA‐SX) alone and in combination with niacin‐bound chromium (NBC) and a standardized Gymnema sylvestre extract (GSE) on weight loss in moderately obese subjects was evaluated by monitoring changes in body weight, body mass index (BMI), appetite, lipid profiles, serum leptin and excretion of urinary fat metabolites. HCA‐SX has been shown to reduce appetite, inhibit fat synthesis and decrease body weight without stimulating the central nervous system. NBC has demonstrated its ability to maintain healthy insulin levels, while GSE has been shown to regulate weight loss and blood sugar levels.
Analytical Chemistry | 2012
Vyomesh Patel; Bhaskara V. Chikkaveeraiah; Bernard Munge; Sok Ching Cheong; Rosnah Binti Zain; Mannil Thomas Abraham; Dipak K. Dey; J. Silvio Gutkind; James F. Rusling
Multiplexed biomarker protein detection holds unrealized promise for clinical cancer diagnostics due to lack of suitable measurement devices and lack of rigorously validated protein panels. Here we report an ultrasensitive electrochemical microfluidic array optimized to measure a four-protein panel of biomarker proteins, and we validate the protein panel for accurate oral cancer diagnostics. Unprecedented ultralow detection into the 5-50 fg·mL(-1) range was achieved for simultaneous measurement of proteins interleukin 6 (IL-6), IL-8, vascular endothelial growth factor (VEGF), and VEGF-C in diluted serum. The immunoarray achieves high sensitivity in 50 min assays by using off-line protein capture by magnetic beads carrying 400,000 enzyme labels and ~100,000 antibodies. After capture of the proteins and washing to inhibit nonspecific binding, the beads are magnetically separated and injected into the array for selective capture by antibodies on eight nanostructured sensors. Good correlations with enzyme-linked immunosorbent assays (ELISA) for protein determinations in conditioned cancer cell media confirmed the accuracy of this approach. Normalized means of the four protein levels in 78 oral cancer patient serum samples and 49 controls gave clinical sensitivity of 89% and specificity of 98% for oral cancer detection, demonstrating high diagnostic utility. The low-cost, easily fabricated immunoarray provides a rapid serum test for diagnosis and personalized therapy of oral cancer. The device is readily adaptable to clinical diagnostics of other cancers.
Arthritis Research & Therapy | 2008
Krishanu Sengupta; Krishnaraju Venkata Alluri; Andey Rama Satish; Simanchala Mishra; Trimurtulu Golakoti; Kadainti V S Sarma; Dipak K. Dey; Siba P. Raychaudhuri
Introduction5-Loxin® is a novel Boswellia serrata extract enriched with 30% 3-O-acetyl-11-keto-beta-boswellic acid (AKBA), which exhibits potential anti-inflammatory properties by inhibiting the 5-lipoxygenase enzyme. A 90-day, double-blind, randomized, placebo-controlled study was conducted to evaluate the efficacy and safety of 5-Loxin® in the treatment of osteoarthritis (OA) of the knee.MethodsSeventy-five OA patients were included in the study. The patients received either 100 mg (n = 25) or 250 mg (n = 25) of 5-Loxin® daily or a placebo (n = 25) for 90 days. Each patient was evaluated for pain and physical functions by using the standard tools (visual analog scale, Lequesnes Functional Index, and Western Ontario and McMaster Universities Osteoarthritis Index) at the baseline (day 0), and at days 7, 30, 60 and 90. Additionally, the cartilage degrading enzyme matrix metalloproteinase-3 was also evaluated in synovial fluid from OA patients. Measurement of a battery of biochemical parameters in serum and haematological parameters, and urine analysis were performed to evaluate the safety of 5-Loxin® in OA patients.ResultsSeventy patients completed the study. At the end of the study, both doses of 5-Loxin® conferred clinically and statistically significant improvements in pain scores and physical function scores in OA patients. Interestingly, significant improvements in pain score and functional ability were recorded in the treatment group supplemented with 250 mg 5-Loxin® as early as 7 days after the start of treatment. Corroborating the improvements in pain scores in treatment groups, we also noted significant reduction in synovial fluid matrix metalloproteinase-3. In comparison with placebo, the safety parameters were almost unchanged in the treatment groups.Conclusion5-Loxin® reduces pain and improves physical functioning significantly in OA patients; and it is safe for human consumption. 5-Loxin® may exert its beneficial effects by controlling inflammatory responses through reducing proinflammatory modulators, and it may improve joint health by reducing the enzymatic degradation of cartilage in OA patients.Trail Registration(Clinical trial registration number: ISRCTN05212803.)
Biometrics | 1997
Dipak K. Dey; Ming-Hui Chen; Hong Chang
SUMMARY In this paper, we propose a general model-determination strategy based on Bayesian methods for nonlinear mixed effects models. Adopting an exploratory data analysis viewpoint, we develop diagnostic tools based on conditional predictive ordinates that conveniently get tied in with Markov chain Monte Carlo fitting of models. Sampling-based methods are used to carry out these diagnostics. Two examples are presented to illustrate the effectiveness of these criteria. The first one is the famous Langmuir equation, commonly used in pharmacokinetic models, whereas the second model is used in the growth curve model for longitudinal data.
Journal of the American Statistical Association | 1999
Ming-Hui Chen; Dipak K. Dey; Qi-Man Shao
Abstract The logit, probit, and student t-links are widely used in modeling dichotomous quantal response data. Most of the commonly used link functions are symmetric, except the complementary log-log link. However, in some applications the overall fit can be significantly improved by the use of an asymmetric link. In this article we propose a new skewed link model for analyzing binary response data with covariates. Introducing a skewed distribution for the underlying latent variable, we develop a class of asymmetric link models for binary response data. Using a Bayesian approach, we first characterize the propriety of the posterior distributions using standard improper priors. We further propose informative priors using historical data from a similar previous study. We examine the proposed method through a large-scale simulation study and use data from a prostate cancer study to demonstrate the use of historical data in Bayesian model fitting and comparison of skewed link models.